These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Type III hyperlipoproteinemia: a focus on lipoprotein receptor-apolipoprotein E2 interactions. Innerarity TL; Hui DY; Bersot TP; Mahley RW Adv Exp Med Biol; 1986; 201():273-88. PubMed ID: 3026150 [No Abstract] [Full Text] [Related]
3. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias. Chait A Spec Top Endocrinol Metab; 1983; 5():1-53. PubMed ID: 6322371 [TBL] [Abstract][Full Text] [Related]
4. Regulation of plasma cholesterol by lipoprotein receptors. Brown MS; Kovanen PT; Goldstein JL Science; 1981 May; 212(4495):628-35. PubMed ID: 6261329 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Brown MS; Goldstein JL Annu Rev Biochem; 1983; 52():223-61. PubMed ID: 6311077 [No Abstract] [Full Text] [Related]
7. [Lipoprotein receptors and atheromatosis]. Masana MarĂn L Med Clin (Barc); 1984 Jun; 83(3):119-21. PubMed ID: 6090823 [No Abstract] [Full Text] [Related]
13. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III). Utermann G Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616 [No Abstract] [Full Text] [Related]
20. Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages. Lindholm EM; Palmer AM; Graham A Biochem J; 2001 Jun; 356(Pt 2):515-23. PubMed ID: 11368780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]